On June 21-22, 2025, the "2025 Academic Conference of the Andrology Professional Committee and Nursing Group of the Chongqing Sexology Association" was successfully held in Chongqing, hosted by the Chongqing Sexology Association and organized by the Affiliated Bishan Hospital of Chongqing Medical University. The conference, themed "Focusing on Core Andrology Techniques and Promoting Full-Cycle Health Management," attracted numerous experts and scholars from the Sichuan-Chongqing region. In-depth discussions were held on topics such as male infertility, assisted reproductive technology, pediatric hormone disorders, prostate diseases, and andrology surgeries, presenting participants with a high-level academic feast.
Professor He Fan, Associate Director of the Department of Urology at Chongqing University Affiliated Central Hospital and Visiting Scholar at the University of Tübingen, Germany, gave a keynote speech on "Low-Intensity Pulsed Ultrasound (LIPUS) for the Treatment of Erectile Dysfunction," systematically explaining the latest clinical advancements in this technology.
As a first-line treatment included in the "Expert Consensus on Erectile Dysfunction Diagnosis and Treatment," WBL LIPUS utilizes the mechanical stimulation effect of low-intensity pulsed ultrasound to activate endogenous stem cells in the penile corpus cavernosum, promoting angiogenesis and tissue repair. Professor He Fan, combining clinical data from Chongqing, pointed out that LIPUS treatment had a success rate of 71% in patients with mild to moderate erectile dysfunction (ED), and its non-invasive nature significantly improved patient compliance. For complex cases like diabetic ED, combining LIPUS with phosphodiesterase type 5 inhibitors (PDE5i) can further enhance corpus cavernosum microcirculation.
WBL LIPUS Technology Principle and Treatment Effect
The core mechanism of WBL LIPUS is the application of low-energy pulsed ultrasound (sound intensity range of 50-350mW/CM²) to the penile corpus cavernosum tissue, activating endogenous stem cells, promoting the regeneration of blood vessels and nerves, and repairing damaged vascular endothelium and nerve matrices, thereby improving erectile function at the pathological level. Compared to traditional oral medications (such as PDE5 inhibitors), prosthetic implants, or invasive therapies (such as corpus cavernosum injections), WBL LIPUS is a safe, non-invasive treatment that does not result in drug dependence, related side effects, or surgical complications.
Competitive Advantages of WBL LIPUS
1.Non-invasiveness and Safety
No medication or surgery required, avoiding liver and kidney burdens and infection risks, especially suitable for patients with chronic diseases (such as diabetes).
2.Comprehensive Treatment Model
Innovative "LIPUS + Psychological Counseling + VR" integrated therapy that addresses both physiological repair and psychological intervention, increasing patient satisfaction by over 30%.
3.Clinical Data Support
Clinically validated by over 60 medical institutions worldwide, with efficacy and safety endorsed by authoritative institutions such as UCSF and Peking University Hospital.
WBL LIPUS Leading the Future
The successful hosting of this conference marks a significant step forward in the technological innovation and standardization development of the andrology field in Chongqing. As a representative technology of microenergy medicine, WBL LIPUS, with its dual advantages of clinical value and humanistic warmth, is becoming a key solution to the challenges of ED treatment. With the deepening of regional cooperation and the improvement of the nursing system, WBL LIPUS is expected to provide more patients with efficient and safe treatment options, contributing to the high-quality development of andrology in China.